Aurobindo Pharma
Aurobindo to buy Sandoz’s dermatology business in US for $1 bn
07 Sep 2018
Aurobindo will pay $900 million for about 300 products, three manufacturing facilities in the US and Eon Labs Inc, a wholly owned unit of Sandoz Inc, besides performance-based payments of $100 million on products in the pipeline
Aurobindo and others in the race to buy Novartis portfolio of US assets
12 May 2018
If Aurobindo Pharma is successful in clinching the deal, it would be the largest acquisition of an overseas business by any Indian drug producer, after Lupin's 2015 acquisitions of Gavis Pharmaceuticals and Novel Laboratories for $880 million, in a cash-free and debt deal
Aurobindo Phrma to set up plant in S Arabia
11 Jan 2016
